共 50 条
Targeting the Tumor Stroma in Cancer Therapy
被引:29
|作者:
Anton, Kevin
[2
]
Glod, John
[1
,2
]
机构:
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Dept Pediat Oncol, New Brunswick, NJ 08903 USA
[2] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Dept Pharmacol, New Brunswick, NJ 08903 USA
关键词:
MESENCHYMAL STEM-CELLS;
ENDOTHELIAL GROWTH-FACTOR;
METALLOPROTEINASE INHIBITOR PRINOMASTAT;
PLASMINOGEN-ACTIVATOR SYSTEM;
TYROSINE KINASE INHIBITOR;
ACUTE MYELOID-LEUKEMIA;
BREAST-CANCER;
PHASE-II;
MACROPHAGE INFILTRATION;
PROTEIN-ALPHA;
D O I:
10.2174/138920109787315088
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
Increasing evidence shows that the interaction between neoplastic cells and the surrounding stroma is a critical factor in solid tumor growth. The tumor stroma is made up of diverse cellular populations including macrophages, lymphocytes, vascular cells, and carcinoma-associated fibroblasts. The complex interactions between the stroma and neoplastic cells are largely unexplored. Initial therapies aimed at disrupting angiogenesis within the tumor microenvironment have met with success in a number of tumor types. An improved understanding of stromal signaling pathways is likely to identify additional novel therapeutic targets.
引用
收藏
页码:185 / 191
页数:7
相关论文